Peroxisome proliferator-activated receptor (PPAR) alpha activation and its consequences in humans

Ashby, 1994, Mechanistically-based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis, Hum. Exp. Toxicol., 13, S1, 10.1177/096032719401300201 Bichet, 1990, Toxicological studies on a benzofuran derivative, Toxicol. Appl. Pharmacol., 106, 509, 10.1016/0041-008X(90)90345-U Blaauboer, 1990, The effect of beclobric acid and clofibric acid on peroxisomal β-oxidation and peroxisome proliferation in primary cultures of rat, monkey and human hepatocytes, Biochem. Pharmacol., 40, 521, 10.1016/0006-2952(90)90551-U Blümcke, 1983, Influence of fenofibrate on cellular and subcellular liver structure in hyperlipidemic patients, Atherosclerosis, 46, 105, 10.1016/0021-9150(83)90169-7 Cattley, 1994, Initiator specific promotion of hepatocarcinogenesis by WT-14 643 and clofibrate, Carcinogenesis, 15, 1763, 10.1093/carcin/15.8.1763 Chance, 1995, Inverse relationship between peroxisomal and mitochondrial β-oxidation in Hep-G2 cells treated with dehydroepiandrosterone and clofibric acid, Proc. Soc. Ex. Biol. Med., 208, 378, 10.3181/00379727-208-43865 Cornu-Chagnon, 1995, Fenofibrate: metabolism and species differences for peroxisome proliferation in cultured hepatocytes, Fundam. Appl. Toxicol., 26, 63, 10.1006/faat.1995.1075 De La Iglesia, 1982, Light and electron microscopy of liver in hyperlipoproteinemic patients under long-term gemfibrozil treatment, Atherosclerosis, 43, 19, 10.1016/0021-9150(82)90096-X Elcomb, 1996, Peroxisome proliferators: species differences in response of primary hepatocyte cultures, Ann. N.Y. Acad. Sci., 804, 624 Frenkel, 1994, The effect of β,β′-methyl-substituted hexadecanedioic acid on plasma VLDL metabolism in rats: role of apolipoprotein C-III, Biochem. J., 298, 409, 10.1042/bj2980409 Frenkel, 1988, The hypochylomicronemic effect of β,β′-methyl-substituted hexadecanedioic acid is mediated by a decrease in apolipoprotein C-III, J. Biol. Chem., 263, 8491, 10.1016/S0021-9258(18)68505-9 Gariot, 1987, Morphometric study of human hepatic cell modifications induced by fenofibrate, Metabolism, 36, 203, 10.1016/0026-0495(87)90177-6 Gibson, G., Lake, B., 1993. Peroxisomes — Biology and Importance in Toxicology and Medicine. Taylor and Francis, London. Gray, 1984, Quantitative microscopy comparison of peroxisome proliferation by the lipid regulating agent gemfibrozil in several species, Hepatology, 4, 520, 10.1002/hep.1840040328 Hanefeld, 1983, Relationship between morphological changes and lipid-lowering action of p-chlorophenoxy isobutyric acid (CPIB) on hepatic mitochondria and peroxisomes in man, Atherosclerosis, 46, 239, 10.1016/0021-9150(83)90115-6 Hertz, 1987, Clofibrate does not induce peroxisomal proliferation in human hepatoma cell lines PLC/PRF/5 and SK-Hep-1, Cancer Lett., 34, 263, 10.1016/0304-3835(87)90176-5 Hertz, 1994, Transcriptional activation by amphipathic carboxylic peroxisomal proliferators is induced by the free acid rather than the acyl-CoA derivative, Eur. J. Biochem., 221, 611, 10.1111/j.1432-1033.1994.tb18773.x Hertz, 1995, Mode of action of peroxisome proliferators as hypolipidemic drugs: suppression of apolipoprotein C-III, J. Biol. Chem., 270, 13470, 10.1074/jbc.270.22.13470 Hertz, 1996, Transcriptional suppression of the transferrin gene by hypolipidemic peroxisome proliferators, J. Biol. Chem., 271, 218, 10.1074/jbc.271.1.218 Hertz, 1998, Fatty acyl-CoA thioesters are ligands of hepatic nuclear factor-4α, Nature, 392, 512, 10.1038/33185 Huber, 1996, Hepatocarcinogeneic potential of di(2-ethylhexyl)phthalate in rodents and its implications on human risk, Crit. Rev. Toxicol., 26, 365, 10.3109/10408449609048302 Hwang, 1993, Induction of sister chromatid exchange and micronuclei in primary cultures of rat and human hepatocytes by the peroxisome proliferator Wy-14 643, Mutat. Res., 286, 123, 10.1016/0027-5107(93)90176-G Inoue, 1998, Expression of peroxisome proliferator-activated receptor alpha (PPARα) in primary cultures of human vascular endothelial cells, Biochem. Biophys. Res. Commun., 246, 370, 10.1006/bbrc.1998.8622 Isseman, 1990, Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators, Nature, 347, 645, 10.1038/347645a0 Kliewer, 1992, Convergence of 9-cis retinoic acid and peroxisome proliferators signalling pathways through heterodimer formation of their receptors, Nature, 358, 771, 10.1038/358771a0 Lee, 1995, Targeted disruption of the α isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators, Mol. Cell Biol., 15, 3012, 10.1128/MCB.15.6.3012 Lemberger, 1994, Regulation of the peroxisome proliferator-activated receptor alpha gene by glucocorticoids, J. Biol. Chem., 269, 24527, 10.1016/S0021-9258(17)31420-5 Mukherjee, 1994, Human and rat peroxisome proliferator activated receptors (PPARs) demonstrate similar tissue distribution but different responsiveness to PPAR activators, J. Steroid Biochem. Mol. Biol., 51, 157, 10.1016/0960-0760(94)90089-2 Osumi, 1991, Two cis-acting regulatory elements in the peroxisome proliferator-response element enhancer region of the acyl-CoA oxidase gene, Biochim. Biophys. Res. Commun., 175, 866, 10.1016/0006-291X(91)91645-S Palmer, 1998, Peroxisome proliferator activated receptor-α expression in human liver, Mol. Pharmacol., 53, 14, 10.1124/mol.53.1.14 Passily, 1996, Toxicological evaluation of peroxisome proliferators, Ann. N.Y. Acad. Sci., 804, 716, 10.1111/j.1749-6632.1996.tb18678.x Rao, 1987, Peroxisome proliferation and hepatocarcinogenesis, Carcinogenesis, 8, 631, 10.1093/carcin/8.5.631 Reddy, 1989, Oxidative DNA damage caused by persistent peroxisome proliferation: its role in hepatocarcinogenesis, Mutat. Res., 214, 63, 10.1016/0027-5107(89)90198-X Reddy, J.K., Suga, T., Mannaerts, G.P., Lazarow, P.B., Suberman, S., 1996. Peroxisomes — Biology and role in toxicology and disease. Ann. N.Y. Acad. Sci. Series, Vol. 804. Sausen, 1995, Gemfibrozil-induced peroxisome proliferation and hepatomegaly in male F-344 rats, Cancer Lett., 97, 263, 10.1016/0304-3835(95)03987-8 Sher, 1993, cDNA cloning, chromosomal mapping and functional characterization of the human peroxisome proliferator activated receptor, Biochemistry, 32, 5598, 10.1021/bi00072a015 Su, 1998, Monitoring of PPARα protein expression in human tissue by the use of PPARα specific Mabs, Hybridoma, 17, 45, 10.1089/hyb.1998.17.47 Tugwood, 1992, The mouse peroxisome proliferator activated receptor recognizes a response element in the 5′ flanking sequence of the rat acyl-CoA oxidase gene, Embo J., 11, 433, 10.1002/j.1460-2075.1992.tb05072.x Tugwood, 1996, Peroxisome proliferator-activated receptors: structure and function, Ann. N.Y. Acad. Sci., 804, 252, 10.1111/j.1749-6632.1996.tb18620.x Varanasi, 1996, Identification of a peroxisome proliferator responsive element upstream of the human peroxisomal fatty acyl coenzyme A oxidase gene, J. Biol. Chem., 271, 2147, 10.1074/jbc.271.4.2147